Introduction 819 Evergreen Fund I
819 Evergreen Fund I Coöperatief U.A. (“819 Evergreen Fund” or “the Fund”) is active as of Oct 1, 2023. The Fund is an open-ended fund with a focus on deep tech, addressing societal challenges in multiple sectors, such as healthcare and tech. The Fund’s predecessor is Lumana Invest.
Long-term perspective
819 Evergreen Fund invests in start-ups and scale-ups in and has a focus on minority interests. We believe that the societal challenges of our time can best be addressed with a long-term perspective. Through our open-ended fund, we can maintain longer-term involvement with companies. While traditional closed-ended funds aim for an exit within a fixed time frame, we can achieve sustainable value creation through better timing. Due to its open-ended fund structure, the Fund is not restricted to any particular investment horizon and therefore does not experience investment and/or exit pressure. Our goal is to sell a business at the right moment for all parties involved.
Sustainable value creation
As shareholders, we actively contribute to the development of our portfolio companies. Our ambition is to establish long-term, flexible partnerships with companies to enable sustainable value creation. We realize that commitment and hard work are essential to achieve success. With passion, knowledge and energy, we dedicate ourselves to building a company together, and we consider this a great challenge.
Investment Criteria for 819 Evergreen Fund
819 Evergreen Fund supports start-up and scale-up companies in deep-tech. We have a specific interest in companies that possess breakthrough innovations and a strong leadership team. We aim to expedite their growth by providing capital, leveraging our expertise, and utilizing our network.
- Deep-tech companies
- Companies addressing societal challenges in (top)sectors such as healthcare and tech
- Companies with an exceptional (leadership) team
- Companies with a promising and distinctive market position
- Companies comply or are actively working on ESGs and/or SDGs
- We have a focus on minority interests
Our initial investment is typically between € 250k and € 2.0M per company, and we prefer to invest in a syndicate.
819 Evergreen Fund I
ScoutinScience
ScoutinScience has developed an AI platform that is trained to automatically scout for ‘hidden gems’ with high tech transfer and business potential in scientific literature and …
More information
819 Evergreen Fund I
Vivolta
Vivolta is a leading player in the development and implementation of electrospinning processes and equipment for the manufacture of medical devices for (regenerative) medicine and drug delivery.
More information
819 Evergreen Fund I
Eurekite
Eurekite’s activities are all focused on its core invention: Flexiramics®. It is a flexible pure ceramic fiber mat that is light and flexible like paper, but …
More information
819 Evergreen Fund IExit
NovioScan
Novioscan is founded in 2014 and holds its office at the NovioTech Campus in Nijmegen, The Netherlands. The development of wearable ultrasound devices was a result …
More information
819 Evergreen Fund I
Atro Medical
The company is addressing a large unmet medical need, as the number of patients with knee pain caused by a meniscectomy increase.
More information
819 Evergreen Fund I
Neuroplast
Neuroplast is a clinical stage biotech that develops the stem cell product Neuro-Cells®
More information
819 Evergreen Fund I
Direct Diagnostics
Direct Diagnostics utilizes advanced technology to provide actionable recommendations and personalized health solutions. The company sells preventive health tests and offers a data-driven eHealth platform for …
More information
819 Evergreen Fund I
Sono-Coat
Sono-Coat is a medical technology company with the mission to improve patient care through innovative visibility solutions for ultrasound guided interventions. The innovative echogenic coating-system provides …
More informationGovernance 819 Evergreen Fund
The investments from 819 Evergreen Fund are supervised by our Investment Board, which consists of a selected group of our investors (Limited Partners, “LPs”). Currently, Mr Brouwer serves as Chairman of the Investment Board. Our Investment Board acts as a check and balance on 819 Capital Partners as fund manager and monitors the Fund’s activities to ensure that these align with the Fund’s objectives and the interests of the LPs.
Regulatory information 819 Evergreen Fund
The Fund is a collective investment undertaking (beleggingsinstelling) within the meaning of section 1:1 of the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht) (“FMSA”). The Fund and its Manager (819 Capital Partners) are registered with the AFM in accordance with section 2:66a of the FMSA (AFM Fund ID: 50033383).
819 Evergreen Fund is an SFDR Article 6 Fund and has no reporting obligations in the field of impact, but does take the Sustainable Development Goals (SDGs) into account when making investments. More information can be found in our ESG Policy.
Contact us
819 Evergreen Fund is open for new investors and investment applications. Feel free to contact us and we will be happy to tell you more about the Fund and conditions.